电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Absent in Melanoma 2 (AIM2) Peptide

AIM2 适用: 人 宿主: 合成 BP, WB
产品编号 ABIN973030
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Absent in Melanoma 2 (AIM2) Peptide (ABIN973030)

抗原

AIM2 (Absent in Melanoma 2 (AIM2))

宿主

资源

  • 10
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB)
  • 产品特性

    This is a synthetic peptide designed for use in combination with anti-AIM2 antibody (Catalog #: ARP50505_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    纯化方法

    Purified
  • 应用备注

    Each Investigator should determine their own optimal working dilution for specific applications.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    浓度

    1 mg/mL

    缓冲液

    Final peptide concentration is 1 mg/mL in PBS.

    注意事项

    Avoid repeated freeze-thaw cycles.

    储存条件

    -20 °C

    储存方法

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • 抗原

    AIM2 (Absent in Melanoma 2 (AIM2))

    背景

    AIM2 is a member of the IFI20X /IFI16 family. It plays a putative role in tumorigenic reversion and may control cell proliferation. Interferon-gamma induces expression of AIM2.AIM2 is a member of the IFI20X /IFI16 family. It plays a putative role in tumorigenic reversion and may control cell proliferation. Interferon-gamma induces expression of AIM2.

    Alias Symbols: PYHIN4

    Protein Size: 343

    分子量

    39 kDa

    基因ID

    9447

    NCBI登录号

    NM_004833, NP_004824

    UniProt

    O14862
You are here: